Cargando…
In Silico and In Vitro Exploration of Poziotinib and Olmutinib Synergy in Lung Cancer: Role of hsa-miR-7-5p in Regulating Apoptotic Pathway Marker Genes
Background and objectives: Non-small cell lung cancer (NSCLC) is often caused by EGFR mutations, leading to overactive cell growth pathways. Drug resistance is a significant challenge in lung cancer treatment, affecting therapy effectiveness and patient survival. However, combining drugs in research...
Autores principales: | Alamery, Salman, AlAjmi, Anfal, Wani, Tanveer A., Zargar, Seema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673591/ https://www.ncbi.nlm.nih.gov/pubmed/38003971 http://dx.doi.org/10.3390/medicina59111923 |
Ejemplares similares
-
Evaluation of the Effect of Wheat Germ Oil and Olmutinib on the Thioacetamide-Induced Liver and Kidney Toxicity in Mice
por: Alamery, Salman, et al.
Publicado: (2022) -
Olmutinib Induced Lichen Planus Like Eruption
por: Oh, Seung Hwan, et al.
Publicado: (2018) -
Effects of dacomitinib on the pharmacokinetics of poziotinib in vivo and in vitro
por: Ji, Weiping, et al.
Publicado: (2021) -
Diffuse scaly erythematous plaques in patient taking poziotinib
por: Oldenburg, Reid, et al.
Publicado: (2021) -
Evaluation of the Possible Pathways Involved in the Protective Effects of Quercetin, Naringenin, and Rutin at the Gene, Protein and miRNA Levels Using In-Silico Multidimensional Data Analysis
por: Zargar, Seema, et al.
Publicado: (2023)